Leading experts Stephan Achenbach, Carlos Aguiar, Emma Svennberg, David Capodanno, and Nicolle Kraenkel discuss the latest developments in cardiovascular medicine, including new pharmacologic approaches for hypertrophic obstructive cardiomyopathy and advancements in intravascular imaging in coronary interventions. They also highlight the Atesia trial, which compares oral anticoagulant therapy for subclinical atrial fibrillation and discuss the top cardiology papers of 2023, including a study on the blood pressure-lowering effects of tomatoes.

Join experts Stephan Achenbach, a leading cardiology figure, Carlos Aguiar, lipid management authority, Kyle Klarich, cardiac specialist, and Konstantinos Koskinas, renowned researcher, as they dive into innovative strategies for managing cardiac fibroelastomas and advancing lipid therapy beyond statins. They discuss the latest research highlighting new therapeutic options, evaluate the effectiveness and side effects of current treatments, and examine the importance of LDL cholesterol reduction in cardiovascular health. A must-listen for those in the field!

Cardiologists Stephan Achenbach, Carlos Aguiar, Michael Boehm, and Lene Holmvang discuss topics like long-term beta blockers post-MI, pros and cons of microaxial pump in cardiogenic shock, patient selection for micro-axial pump, and benign cardiac imaging findings in an informative and engaging manner.

Stephan Achenbach, a leading cardiology expert, joins Carlos Aguiar, a top atrial fibrillation researcher, Jane Armitage, a clinician renowned for her work on clinical trials, and Isabel Deisenhofer, an authority on cardiovascular study evaluation. They dive into strategic decisions in managing atrial fibrillation, discussing new guidelines that emphasize rhythm control and catheter ablation. The group also explores the importance of designing reliable clinical trials and the need for patient involvement in advanced cardiac treatment decisions.

Exploring the dangers of sexual activity for heart disease patients, plastic debris in heart disease plaques, categorizing patients for cardiovascular safety during sex, addressing sexual health for cardiac patients, and managing rheumatic heart disease challenges.